Josep Tabernero

Dr. Tabernero, Head of the Medical Oncology Department and Director of VHIO in Barcelona, is recognized globally for his contributions to cancer research and leadership, particularly in the areas of gastrointestinal cancers and early-phase oncology drug development. He served as President of the European Society for Medical Oncology (ESMO) from 2018–2019 and has been an active member of its Executive Board and multiple educational and scientific committees within ESMO, ASCO, and AACR. He currently serves as the Chair of Cancer Core Europe and as a member of the Board of Directors of the Organization of European Cancer Institutes (OECI). Dr. Tabernero has (co)-authored approximately 600 peer-reviewed papers with an H-Index of 115, and he currently serves on the editorial boards of leading oncology journals including Annals of Oncology, ESMO Open, Cancer Discovery, Clinical Cancer Research, Cancer Treatment Reviews, and Nature Reviews Clinical Oncology, as well as on the scientific advisory boards of several major pharmaceutical and biotechnology companies.